MoneyWorks4Me

Hester Biosciences informs about earnings conference call

31 Oct 2019 Evaluate

Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Wednesday, 6 November 2019 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30 September 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..